NorthWest Biotherapeutics Inc (NWBO)

[Truthfan]

An interesting interview with Merck’s Perlmutter. I was amused at the reference to “orange juice” in this exhange:

“Xconomy: Several oncologists believe there isn’t enough basic research and too much spaghetti-against-the-wall when it comes to clinical trials for combinations. What is your response?

RP: The philosophical underpinnings of our approach have integrity. It’s not like we do everything. To those who are concerned that we’re just saying, “Oh, what the hell, let’s try anything, orange juice, mineral oil, whatever”—we are thinking this through very carefully. Among the literally hundreds of things we could do, we select just a few. Although we have more than 450 combination studies ongoing, it’s the product of a very thoughtful, precise selection.”



Merck’s Perlmutter interview regarding Keytruda (Jan 2019)

https://xconomy.com/national/2019/01/16/merck-and-the-future-of-immuno-oncology-a-chat-with-roger-perlmutter/